Gynecologic Cancers | Meet The Professor: Immunotherapy and Novel Agents in Gynecologic Cancers

published 5 months ago by Dr Neil Love

Featuring perspectives from Dr Michael J Birrer on the following topics: Anti-PD-1/PD-L1 Checkpoint Inhibitors for Gynecologic Cancers (0:00) HER2-Positive Endometrial Cancer (43:24) Tisotumab Vedotin and Other Novel Agents in Gynecologic Cancers (47:57) CME information and select publications

more episodes from Research To Practice | Oncology Videos